August 1, 2020
Coronavirus

FOX NEWS: Your COVID-19 manual: a doctor’s advice on how to treat at home

coronavirus, COVID-19, covid19

Play Video

HOUSTON – A doctor wrote a book called the COVID-19 Survival Manual, hoping to help people treat themselves at home and stay out of the hospital, all while his company is trying to develop a nasal spray to help treat it.

Dr. Steven Quay, President and CEO of Atossa Therapeutics, wants us to understand what he calls three phases of COVID-19. He says the first two phases can usually be treated at home, but the third means a trip to the hospital. The goal is to treat the first two phases at home to prevent your body from slipping into the third phase.

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen’s Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer

October 31, 2024

This video describes the clinical data from the Atossa Therapeutics press release of October 31, 2024 entitled, Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen’s Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer

Dr. Quay featured in CBS7 on New 2024 COVID Vaccine

September 4, 2024

This summer saw a rise in COVID-19 infections across the U.S., driven by a new variant. To address this, updated vaccines from Moderna and Pfizer have been approved by the FDA and will be available this fall. The CDC notes the virus has been evolving, making regular vaccinations important, especially for those with underlying health conditions.

Lanzamiento de la Nueva Vacuna contra el COVID-19: Lo Que Necesitas Saber para el Otoño de 2024

August 31, 2024

Los casos de COVID-19 están aumentando ligeramente en EE. UU., y se introducirá una nueva vacuna este otoño. Telemundo20 en Texas conversa con el Dr. Quay para discutir los datos más recientes sobre esta vacuna y las precauciones que las personas deben considerar para los próximos meses. A pesar de la presencia continua del virus, actualmente es menos infeccioso y se asemeja a un resfriado común en términos de transmisión.

Join Dr. Quay’s ElevatorMedicine™ and get FREE, QUICK TIPS for better living, health, and wellness that take less time than riding an elevator!